|
| 37503747 | The associations of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors as add-on to metformin with fracture risk in patients with type 2 diabetes mellitus. | | 2023 |
| 35896043 | Primary nonadherence to drugs prescribed by general practitioners: A Dutch database study. | British Journal of Clinical Pharmacology | 2023 |
| 37663263 | Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis. | Front Pharmacol | 2023 |
| 37280706 | Heterogeneity after harmonisation: A retrospective cohort study of bleeding and stroke risk after the introduction of direct oral anticoagulants in four Western European countries. | | 2023 |
| 37024736 | Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First Dose. | Drug Saf | 2023 |
| 36890111 | Prescribing of low-dose rivaroxaban in patients with atherosclerotic cardiovascular disease in the United Kingdom and the Netherlands. | | 2023 |
| 37264679 | Improving 10-year cardiovascular risk prediction in apparently healthy people: flexible addition of risk modifiers on top of SCORE2. | Eur J Prev Cardiol | 2023 |
| 37070758 | Bias in observational studies on the effectiveness of in hospital use of hydroxychloroquine in COVID-19. | | 2023 |
| 37294532 | Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study. | Drug Saf | 2023 |
| 35080623 | Challenges in the Design, Registration, and Reporting of Noninferiority Trials. | JAMA Psychiatry | 2022 |
| 35842030 | Use of sodium-glucose co-transporter 2 inhibitors, changes in body mass index and risk of fracture: A population-based cohort study. | Diabetes Research and Clinical Practice | 2022 |
| 35575214 | Mapping the risk of infections in patients with multiple sclerosis: A multi-database study in the United Kingdom Clinical Practice Research Datalink GOLD and Aurum. | Multiple Sclerosis Journal | 2022 |
| 35429893 | Characteristics of patients with lung cancer in clinical practice and their potential eligibility for clinical trials evaluating tyrosine kinase inhibitors or immune checkpoint inhibitors. | Cancer Epidemiology | 2022 |
| 36506571 | Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries. | Front Pharmacol | 2022 |
| 34340993 | Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds. | Heart | 2022 |
| 33131224 | The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs. | International Journal of Health Policy and Management | 2022 |
| 32730628 | Impact of opioids on P2Y12 receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial. | European Heart Journal - Cardiovascular Pharmacotherapy | 2022 |
| 35296459 | The neurological safety of covid-19 vaccines. | BMJ, The | 2022 |
| 35265981 | Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study. | European Heart Journal | 2022 |
| 35227451 | Key Considerations in the Health Technology Assessment of Advanced Therapy Medicinal Products in Scotland, The Netherlands, and England. | Value in Health | 2022 |
| 34779004 | Pre-approval and post-approval availability of evidence and clinical benefit of conditionally approved cancer drugs in Europe: A comparison with standard approved cancer drugs. | British Journal of Clinical Pharmacology | 2022 |
| 34547260 | Impact of vomiting on P2Y12 platelet inhibition in patients with ST-elevation myocardial infarction: A prespecified subanalysis of the ON-TIME 3 trial. | American Heart Journal | 2022 |
| 34446436 | Strengthening international surveillance of vaccine safety. | BMJ, The | 2021 |
| 32324233 | Long-term persistence and adherence with non-vitamin K oral anticoagulants in patients with atrial fibrillation and their associations with stroke risk. | European Heart Journal - Cardiovascular Pharmacotherapy | 2021 |
| 31665368 | Association of preceding antithrombotic therapy in atrial fibrillation patients with ischaemic stroke, intracranial haemorrhage, or gastrointestinal bleed and mortality. | European Heart Journal - Cardiovascular Pharmacotherapy | 2021 |
| 34129693 | Thiazolidinediones and Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study. | Hepatology | 2021 |
| 33593688 | Estimation of manufacturing development costs of cell-based therapies: a feasibility study. | Cytotherapy | 2021 |
| 33543516 | Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants. | British Journal of Clinical Pharmacology | 2021 |
| 34173286 | Major bleeding in users of direct oral anticoagulants in atrial fibrillation: A pooled analysis of results from multiple population-based cohort studies. | Pharmacoepidemiology and Drug Safety | 2021 |
| 33531528 | Effect of metabolic genetic variants on long-term disease comorbidity in patients with type 2 diabetes. | Sci Rep | 2021 |
| 33894280 | Determinants of treatment modification before and after implementation of the updated 2015 NICE guideline on type 2 diabetes: A retrospective cohort study. | Diabetes Research and Clinical Practice | 2021 |
| 33786991 | Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies. | Clinical and Translational Science | 2021 |
| 33733533 | Greedy caliper propensity score matching can yield variable estimates of the treatment-outcome association-A simulation study. | Pharmacoepidemiol Drug Saf | 2021 |
| 33834576 | A systematic review of how missing data are handled and reported in multi-database pharmacoepidemiologic studies. | Pharmacoepidemiology and Drug Safety | 2021 |
| 34263667 | Comprehensive evaluation of post-approval regulatory actions during the drug lifecycle - a focus on benefits and risks. | Expert Opinion on Drug Safety | 2021 |
| 34144957 | Global covid-19 vaccine rollout and safety surveillance-how to keep pace. | BMJ | 2021 |
| 34096584 | Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries. | Europace | 2021 |
| 33768234 | Response to: Kumar N, Ahmed M. Letter to the editor in response to Komen et al. 2021. | European Heart Journal - Cardiovascular Pharmacotherapy | 2021 |
| 32767909 | Use of Sodium-Glucose Co-Transporter-2-Inhibitors (SGLT2-Is) and Risk of Lower Limb Amputation. | | 2021 |
| 33037766 | Prescribers' compliance with summary of product characteristics of dabigatran, rivaroxaban and apixaban-A European comparative drug utilization study. | Basic and Clinical Pharmacology and Toxicology | 2021 |
| 33295644 | Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in extensive disease small cell lung cancer. | Pharmacoepidemiology and Drug Safety | 2021 |
| 32627222 | Comparing risk of major bleeding between users of different oral anticoagulants in patients with nonvalvular atrial fibrillation. | British Journal of Clinical Pharmacology | 2021 |
| 34803665 | Adherence to Direct Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Cross-National Comparison in Six European Countries (2008-2015). | Frontiers in Pharmacology | 2021 |
| 34396634 | Drug exposure misclassification in pharmacoepidemiology: Sources and relative impact. | Pharmacoepidemiology and Drug Safety | 2021 |
| 34671649 | Sex Differences in Platelet Reactivity in Patients With ST-Elevation Myocardial Infarction: A Sub-Analysis of the ON-TIME 3 Trial. | Frontiers in Cardiovascular Medicine | 2021 |
| 31297751 | Managing Uncertainties Due to Limited Evidence in Economic Evaluations of Novel Anti-Tuberculosis Regimens: A Systematic Review. | PharmacoEconomics - Open | 2020 |
| 32369865 | Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic. | Pharmacoepidemiology and Drug Safety | 2020 |
| 32248313 | A novel method for predicting the budget impact of innovative medicines: validation study for oncolytics. | | 2020 |
| 32414635 | What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings. | Cytotherapy | 2020 |
| 31839908 | Affordability of oncology drugs: accuracy of budget impact estimations. | | 2020 |